Puma Biotechnology (PBYI) Shares Soar On Breast Cancer Drug Results
Pfizer Inc. (PFE) Backs Out of Funding Puma Biotechnology (PBYI) Cancer Drug Trials
Biogen Idec, Inc. (Massachusetts) (BIIB) Second Quarter 2014 Revenues Increase 40% To $2.4 Billion; Company Raises Financial Guidance For The Year
Myriad RBM, Inc. To Downsize And Move Operations To Austin, Texas
ArmaGen Technologies, Inc. Licenses AGT-182 Rights To Shire For Up To $225M
U.S. FDA Approves Gilead Sciences, Inc. (GILD)'s Zydelig® (idelalisib) For Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma And Small Lymphocytic Lymphoma
Mylan Inc. (MYL)'s Overseas Move Will Lower Tax Rate
Welichem Announces Termination Of Asset Purchase Agreement And Update On Compulsory Acquisition
FDA Approves Eagle Pharmaceuticals (EGRX)' Ryanodex® For The Treatment Of Malignant Hyperthermia
Health Canada Approves Kane Biotech Inc. (KNE)'s DispersinB® For Human Use
Sofinnova Ventures Raises $500 Million Biotech Venture Fund
Major Advance In UCB Pipeline: Positive Topline Phase 3 Results For brivaracetam In Epilepsy Patients With Partial-Onset Seizures
Taiho Pharmaceutical Invests US $30 Million In Remiges Biopharma Fund, LP
Shire Share Price: Chief Executive Set For $10 Million 'Golden Hello'
ConMed Corporation (CNMD) Announces Leadership Transition
Zenith Epigenetics Appoints Julie Cherrington As President And CEO
Mela Sciences (MELA) Announces $27.3 Million Private Placement Of Preferred Stock, Debentures And Warrants
Eli Lilly and Company (LLY) To Cut Up To 100 Indy Jobs, Send Some Work Overseas
See All News >
Eli Lilly and Company (LLY) To Cut Up To 100 Indy Jobs, Send Some Work Overseas
Major Restructure At Allergan Inc. (AGN) Amid Valeant Pharmaceuticals International (VRX) Takeover Battle; Allergan Inc. To Cut 1,500 Jobs
Synlogic Secures $29.4 Million Series A Financing Led By Atlas Venture
Candid Advice For Cash-Strapped Startups From A Biotech VC; Success At Lumena Pharmaceuticals
Cambridge-Based Broad Institute To Receive Largest Gift Worldwide: $650 Million
Avalanche Biotechnologies Boosts IPO As 2 More Biotechs Go Public This Week
ViiV Healthcare: HIV Combo Therapy Candidate Fails Phase 3
Agena Biosciences Appoints Peter Dansky As Chief Executive Officer
Cancer Biotech Loxo Oncology Sets Terms For $57 Million IPO
FDA Grants Genentech (RHHBY)’s Avastin Priority Review For Recurrent Platinum-Resistant Ovarian Cancer
Drive to Add FDA Drug Police In India Delayed
SAGE Therapeutics Receives Fast Track Designation For Lead Compound SAGE-547 To Treat Status Epilepticus
Large Allergan Inc. (AGN) Investor Sells Most Of Stake
Can Anything Stop Drug Companies From Fleeing The U.S. Tax System?
Cancer Genetics, Inc. (CGIX) Announces Acquisition Of Gentris Corporation, A Leading Global Pharmacogenomics Company, And Increases Contract Backlog To Over $18 Million
Anacor Pharmaceuticals, Inc. (ANAC) Inks Exclusive Deal With Sandoz, Inc. For Kerydin; Anacor To Receive Upfront $40 Million
Aduro Biotech Receives Breakthrough Therapy Designation From FDA For Innovative Pancreatic Cancer Combination Immunotherapy
Amgen (AMGN) Abruptly Puts 70 People On Leave, Cuts Jobs
See All News >